Cardiac innervation and clinical correlates in idiopathic parkinson's disease

Nuclear Medicine Communications

Volumn 24, Issue 3, 2003, Pages 267-271

  Akincioglu A ^a   UNLU M ^a   TunC T ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Cardiac dysautonomia; Heart rate variability; I MIBG; Idiopathic Parkinson's disease; Plasma catecholamine; Scintigraphy; UPDRS score; adrenergic innervation

Indexed keywords

(3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DAILY LIFE ACTIVITY; FEMALE; HEART MUSCLE CONDUCTION SYSTEM; HEART RATE; HUMAN; MALE; MIDDLE AGED; PARKINSON DISEASE; PATHOPHYSIOLOGY; REFERENCE VALUE; SCINTISCANNING;

3-IODOBENZYLGUANIDINE; ACTIVITIES OF DAILY LIVING; ADULT; AGED; FEMALE; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; RADIOPHARMACEUTICALS; REFERENCE VALUES;

EID: 0141653827     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200303000-00006     Document Type: Article

References (32)

1. Parkinson J. An essay on the shaking palsy. London: Whittingham and Rowland, 1817.
2. Koike Y, Takahashi A. Autonomic dysfunction in Parkinson's disease. Eur Neurol 1997; 38(Suppl. 2): 8-12.
3. Meco G, Pratesi L, Bonifati V. Cardiovascular reflexes and autonomic dysfunction in Parkinson's disease. J Neurol 1991; 238: 195-199.
4. Ohama E, Ikuta F. Parkinson's disease: distribution of Lewy bodies and monoamine neuron system. Acta Neuropathol 1976; 34: 311-319.
5. Langston JW, Forno LS. The hypothalamus in Parkinson disease. Ann Neurol 1978; 3: 129-133.
6. Hunters S. The rostral mesencephalon in Parkinson's disease and Alzheimer's disease. Acta Neuropathol 1985; 68: 53-58.
7. Oppenheimer DR. Lateral horn cells in progressive autonomic failure. J Neurol Sci 1980; 46: 393-404.
8. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1992; 85(Suppl. 1): 177-191.
9. Hohnlose SH. Heart rate variability used as an arrhythmia risk stratifier after myocardial infarction. PACE 1997; 2: 123-126.
10. Henderson EB, Kahn JK, Corbett JR, et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988; 78: 1192-1199.
11. 123I-MIBG uptake and increased clearance in various cardiac diseases. Nucl Med Commun 1994; 15: 317-323.
12. Mäntysaari M, Kuikka J, Mustonen J, et al. Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using 123I-metaiodobenzylguanidine. Diabetes 1992; 41: 1069-1075.
13. Malik M, Camm AJ. Heart rate variability and clinical cardiology. Br Heart J 1994; 71: 3-6.
14. Task Force of European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart Rate Variability. Standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93: 1043-1065.
15. Ramaekers D, Ector H, Aubert AE, Rubens A, Van de Werf F. Heart rate variability in healthy volunteers. Eur Heart J 1998; 19: 1334-1341.
16. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-442.
17. Fahn S, Elton RL. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, eds. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Healthcare Information, 1987: 153-163.
18. Calne DB, Brennan J, Spiers ASD, Stern GM. Hypotension caused by L-Dopa. Br Med J 1970; 1: 474-475.
19. Turkka J, Suominen K, Tolonen U, Sotaniemi K, Myllyla VV. Selegiline diminishes cardiovascular autonomic responses in Parkinson's disease. Neurology 1997; 48: 662-667.
20. Korkushko OV, Shatilo VB, Plachinda YI, Shatilo TV. Autonomic control of cardiac chronotropic function in man as a function of age: assessment by power spectral analysis of heart rate variability. J Auton Nerv Syst 1991; 32: 191-198.
21. Piha SJ, Rinne JO, Rinne UK, Seppanen A. Autonomic dysfunction in recent onset and advanced Parkinson's disease. Clin Neurol Neurosurg 1988; 90: 221-226.
22. Kanzaki N, Sato K, Hayabara T. Improved cardiac iodine-123 MIBG accumulation after drug therapy in a patient with PD. Clin Nucl Med 1997; 22: 697-699.
23. Awerbuch GI, Sandyk R. Autonomic functions in early stages of Parkinson's disease. Int J Neurosci 1992; 64: 7-14.
24. Van Dijk JG, Haan J, Zwinderman K, Kremer B, Van Hilten BJ, Roos RAC. Autonomic nervous system dysfunction in Parkinson's disease: relationships with age, medication, duration, and severity. J Neurol Neurosurg Psychiatr 1993; 56: 1090-1095.
25. Takatsu H, Nishida H, Matsuo H, et al. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med 2000; 41: 71-77.
26. Wakabayashi K. Parkinson's disease: the distribution of Lewy bodies in the peripheral autonomic nervous system. Brain Nerve 1993; 45: 965-971.
27. Iwanaga K, Wakabayashi K, Yoshimoto M, et al. Lewy-body type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. Neurology 1999; 52: 1269-1271.
28. Goldstein DS, Holmes C, Cannon RO, Eisenhofer G, Kopin IJ. Sympathetic cardioneuropathy in dysautonomias. N Engl J Med 1997; 336: 696-702.
29. Satoh A, Serita T, Seto M, Tomita I, Satoh H, Iwanaga K. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value. J Nucl Med 1999; 40: 371-375.
30. Braune S, Reinhardt M, Schnitzer R, Riedel A, Lucking CH. Cardiac uptake of 123I-MIBG separates Parkinson's disease from multiple system atrophy. Neurology 1999; 53: 1020-1025.
31. 123I-MIBG in Parkinson's disease. Nucl Med Commun 1998; 19: 137-142.
32. Takatsu H, Nagashima K, Murase M, et al. Differentiating Parkinson's disease from multiple-system atrophy by measuring cardiac iodine-123 metaiodobenzylguanidine accumulation. J Am Med Assoc 2000; 284: 44-45.